Atypical presentations of thrombotic thrombocytopenic purpura: A review

Journal of Clinical Apheresis

Volumn 24, Issue 1, 2009, Pages 47-52

  Sarode, Ravi ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Ccute MI; Rituximab; Stroke; Thrombotic thrombocytopenic purpura

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; RITUXIMAB; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ACUTE CORONARY SYNDROME; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; EARLY DIAGNOSIS; HUMAN; PANCREATITIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PROTEIN FUNCTION; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; VISUAL DISORDER;

ADAM PROTEINS; ADULT; ANEMIA, HEMOLYTIC; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; KIDNEY FAILURE; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOCYTOPENIA;

EID: 63249107524     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20182     Document Type: Review

References (35)

1. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-159.
2. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991;325:393-397.
3. Sarode R, Gottschall JL, Aster RH, McFarland JG. Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 1997;54:102-107.
4. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle pulmonary artery, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-1584.
5. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopeni purpura. N Engl J Med 1998;339:1585-1594.
6. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr., Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
7. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 2005;115:2752-2761.
8. Tsai HM, Chandler WL, Sarode R, Hoffman R, Jelacic S, Habeeb RL, Watkins SL, Wong CS, Williams GD, Tarr PI. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 2001;49:653-659.
9. Aksay E, Kiyan S, Ersel M, Hudaverdi O. Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke. Emerg Med J 2006;23:e51.
10. Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. Arch Intern Med 1925;36:89-93.
11. Dhawan S, Tak T. Myocardial infarction in a patient with thrombotic thrombocytopenic purpura. Int J Cardiol 2004;95: 339-341.
12. Ho HH, Minutello R, Juliano N, Wong SC. A rare cause of acute myocardial infarction: thrombotic thrombocytopenic purpura. Int J Cardiol 2008, DOI 10.1016/j.ijcard.2007.08.063.
13. Patschan D, Witzke O, Duhrsen U, Erbel R, Philipp T, Herget-Rosenthal S. Acute myocardial infarction in thrombotic microangiopathies - clinical characteristics, risk factors and outcome. Nephrol Dial Transplant 2006;21:1549-1554.
14. Perez L, Ramappa P, Guzman JA. Myocardial injury in thrombotic thrombocytopenic purpura: a frequent, perplexing complication. Int J Cardiol 2008;128:257-260.
15. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 2008;48:382-392.
16. Downes KA, Yomtovian R, Tsai HM, Silver B, Rutherford C, Sarode R. Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. J Clin Apher 2004;19:86-89.
17. Tsai HM, Shulman K. Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura. Eur J Haematol 2003;70:183-185.
18. Kondo K, Yamawaki T, Nagatsuka K, Miyashita K, Naritomi H. Reversible stenosis of major cerebral arteries demonstrated by MRA in thrombotic thrombocytopenic purpura. J Neurol 2003;250:995-997.
19. Yacoub A, Kohen I, Francis A. Catatonia with thrombotic thrombocytopenic purpura. Psychosomatics 2004;45:363-364.
20. Patel MR, Bains AK, O'Hara JP, Kallab AM, Marcus DM. Purtscher retinopathy as the initial sign of thrombotic thrombocytopenic purpura/ hemolytic uremic syndrome. Arch Ophthalmol 2001;119:1388-1389.
21. Hay-Smith G, Sagoo MS, Raina J. Fatal thrombotic thrombocytopenia purpura presenting with choroidal vasculopathy and serous retinal detachment. Eye 2006;20:982-984.
22. Costa JR, Krause M, Friedman E, D'Amico DJ. Central retinal vein occlusion in a patient with thrombotic thrombocytopenic purpura. Am J Ophthalmol 2001;131:669-671.
23. Issa SA, Qasem Q. Central retinal vein occlusion associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: complete resolution is possible. J Postgrad Med 2007;53:183-184.
24. Schwartz SG, McPherson AR, Mieler WF, Sessoms SL, Moake JL, Holz ER. Bilateral combined occlusion of the central retinal artery and vein secondary to thrombotic thrombocytopenic purpura. Arch Ophthalmol 2000;118:1304-1305.
25. Swisher KK, Doan JT, Vesely SK, Kwaan HC, Kim B, Laemmle B, Kremer Hovinga JA, George JN. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica 2007; 92:936-943.
26. Naqvi TA, Baumann MA, Chang JC. Post-operative thrombotic thrombocytopenic purpura: a review. Int J Clin Pract 2004;58: 169-172.
27. Basic-Jukic N, Kes P, Brunetta B. Fatal relapse of thrombotic thrombocytopaenic purpura after cardiac surgery in patient with congenital absence of vWF-cleaving protease activity. Nephrol Dial Transplant 2006;21:1734-1735.
28. Cataland SR, Jin M, Smith E, Stanek M, Wu HM. Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme. J Thromb Haemost 2006;4:2733-2737.
29. Robertson MD, Zumberg M. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature. Am J Hematol 2007;82:224-228.
30. Hamilton CA, Kao JM, Coutre SE, Teng NN. Acute post-operative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol 2007;106:423-426.
31. Tao A, Anthony K, Peng Y, Choi H, Nolasco L, Rice L, Moake JL, Dong J-F. Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. J Thromb Haemost 2006;4:1931-1935.
32. Scott EA, Puca KE, Pietz BC, Duchateau BK, Friedman KD. Comparison and stability of ADAMTS13 activity in therapeutic plasma products. Transfusion 2007;47:120-125.
33. Allford SL, Harrison P, Lawrie AS, Liesner R, MacKie IJ, Machin SJ. Von Willebrand factor - cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol 2000;111:1215-1222.
34. Lester WA, Williams MD, Allford SL, Enayat MS, Machin SJ. Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y. Br J Haematol 2002;119:176-179.
35. Scully M, Gattens M, Khair K, Liesner R. The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpura. Br J Haematol 2006;135:101-104.